Transforming growth factor-β1 selectively inhibits hepatocyte growth factor expression via a micro-RNA-199-dependent posttranscriptional mechanism

Molecular Biology of the Cell

Volumn 24, Issue 13, 2013, Pages 2088-2097

  Mungunsukh, Ognoon ^a   Day, Regina M ^a  

^a UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LUCIFERASE; MESSENGER RNA; MICRORNA; MICRORNA 199; NEUROKININ 2 RECEPTOR; SCATTER FACTOR; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; DOWN REGULATION; EPITHELIUM CELL; HUMAN; HUMAN CELL; LUNG FIBROBLAST; PRIORITY JOURNAL; PROTEIN EXPRESSION; WOUND HEALING;

3' UNTRANSLATED REGIONS; ADULT; BASE SEQUENCE; CELL PROLIFERATION; FIBROBLASTS; FORESKIN; GENE EXPRESSION REGULATION; GENES, REPORTER; HEPATOCYTE GROWTH FACTOR; HUMANS; INFANT, NEWBORN; LUCIFERASES; LUNG; MALE; MICRORNAS; MOLECULAR SEQUENCE DATA; MUTAGENESIS, SITE-DIRECTED; PRIMARY CELL CULTURE; PROTEIN ISOFORMS; RNA PROCESSING, POST-TRANSCRIPTIONAL; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA1;

EID: 84879618751     PISSN: 10591524     EISSN: 19394586     Source Type: Journal    
DOI: 10.1091/mbc.E13-01-0017     Document Type: Article

References (65)

1. Ahmet I, Sawa Y, Iwata K, Matsuda H (2002). Gene transfection of hepatocyte growth factor attenuates cardiac remodeling in the canine heart: a novel gene therapy for cardiomyopathy. J Thorac Cardiovasc Surg 124, 957-963. (Pubitemid 35253244)
2. Aoki S, Takahashi K, Matsumoto K, Nakamura T (1997). Activation of Met tyrosine kinase by hepatocyte growth factor is essential for internal organogenesis in Xenopus embryo. Biochem Biophys Res Commun 234, 8-14. (Pubitemid 27267521)
3. Azuma J, Taniyama Y, Takeya Y, Iekushi K, Aoki M, Dosaka N, Matsumoto K, Nakamura T, Ogihara T, Morishita R (2006). Angiogenic and antifibrotic actions of hepatocyte growth factor improve cardiac dysfunction in porcine ischemic cardiomyopathy. Gene Therapy 13, 1206-1213. (Pubitemid 44184714)
4. Bagga S, Bracht J, Hunter S, Massirer K, Holtz J, Eachus R, Pasquinelli AE (2005). Regulation by let-7 and lin-4 miRNAs results in target mRNA degradation. Cell 122, 553-563. (Pubitemid 41191154)
5. Biernacka A, Dobaczewski M, Frangogiannis NG (2011). TGF-beta signaling in fibrosis. Growth Factors 29, 196-202.
6. Border W, Noble N (1994). Transforming growth factor β in tissue fibrosis. N Engl J Med 10, 1286-1292. (Pubitemid 24333194)
7. Bottaro DP, Rubin JS, Faletto DL, Chan AM, Kmiecik TE, Vande Woude GF, Aaronson SA (1991). Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product. Science 251, 802-804. (Pubitemid 21926175)
8. Brennecke J, Stark A, Russell RB, Cohen SM (2005). Principles of microRNA-target recognition. PLoS Biol 3, e85.
9. 1 is present at sites of extracellular matrix gene expression in human pulmonary fibrosis. Proc Natl Acad Sci USA 88, 6642-6646.
10. Chen CY, Gherzi R, Ong SE, Chan EL, Raijmakers R, Pruijn GJ, Stoecklin G, Moroni C, Mann M, Karin M (2001). AU binding proteins recruit the exosome to degrade ARE-containing mRNAs. Cell 107, 451-464. (Pubitemid 33152781)
11. Cioce V, Csaky KG, Chan AM, Bottaro DP, Taylor WG, Jensen R, Aaronson SA, Rubin JS (1996). Hepatocyte growth factor (HGF)/NK1 is a naturally occurring HGF/scatter factor variant with partial agonist/antagonist activity. J Biol Chem 271, 13110-13115. (Pubitemid 26175887)
12. Davis BN, Hilyard AC, Lagna G, Hata A (2008). SMAD proteins control DROSHA-mediated microRNA maturation. Nature 454, 56-61. (Pubitemid 351931982)
13. Davis BN, Hilyard AC, Nguyen PH, Lagna G, Hata A (2010). Smad proteins bind a conserved RNA sequence to promote microRNA maturation by Drosha. Mol Cell 39, 373-384.
14. Day RM, Cioce V, Breckenridge D, Castagnino P, Bottaro DP (1999). Differential signaling by alternative HGF isoforms through c-Met: activation of both MAP kinase and PI 3-kinase pathways is insufficient for mitogenesis. Oncogene 18, 3399-3406. (Pubitemid 29286986)
15. Desmouliere A, Geinoz A, Gabbiani F, Gabbiani G (1993). Transforming growth factor-β1 induces α-smooth muscle actin expression in granulation tissue myofibroblasts and in quiescent and growing cultured fibroblasts. J Cell Biol 122, 103-111. (Pubitemid 23188802)
16. Doeppner TR, Kaltwasser B, ElAli A, Zechariah A, Hermann DM, Bahr M (2011). Acute hepatocyte growth factor treatment induces long-term neuroprotection and stroke recovery via mechanisms involving neural precursor cell proliferation and differentiation. J Cereb Blood Flow Metab 31, 1251-1262.
17. Fukuyama R, Ichijoh Y, Minoshima S, Kitamura N, Shimizu N (1991). Regional localization of the hepatocyte growth factor (HGF) gene to human chromosome 7 band q21.1. Genomics 11, 410-415.
18. Gong R, Rifai A, Tolbert EM, Centracchio JN, Dworkin LD (2003). Hepatocyte growth factor modulates matrix metalloproteinases and plasminogen activator/plasmin proteolytic pathways in progressive renal interstitial fibrosis. J Am Soc Nephrol 14, 3047-3060. (Pubitemid 37509283)
19. Guidi M, Muinos-Gimeno M, Kagerbauer B, Marti E, Estivill X, Espinosa-Parrilla Y (2010). Overexpression of miR-128 specifically inhibits the truncated isoform of NTRK3 and upregulates BCL2 in SH-SY5Y neuroblastoma cells. BMC Mol Biol 11, 95.
20. Hagiwara S, Otsuka T, Yamazaki Y, Kosone T, Sohara N, Ichikawa T, Sato K, Kakizaki S, Takagi H, Mori M (2008). Overexpression of NK2 promotes liver fibrosis in carbon tetrachloride-induced chronic liver injury. Liver Int 28, 126-131.
21. Harrison P, Bradley L, Bomford A (2000). Mechanism of regulation of HGF/SF gene expression in fibroblasts by TGF-beta1. Biochem Biophys Res Commun 271, 203-211. (Pubitemid 30444878)
22. Hegab AE, Kubo H, Yamaya M, Asada M, He M, Fujino N, Mizuno S, Nakamura T (2008). Intranasal HGF administration ameliorates the physiologic and morphologic changes in lung emphysema. Mol Ther 16, 1417-1426.
23. Igawa T, Matsumoto K, Kanda S, Saito Y, Nakamura T (1993). Hepatocyte growth factor may function as a renotropic factor for regeneration in rats with acute renal injury. Am J Physiol 265, F61-F69.
24. Ishikawa T, Factor VM, Marquardt JU, Raggi C, Seo D, Kitade M, Conner EA, Thorgeirsson SS (2012). Hepatocyte growth factor/c-met signaling is required for stem-cell-mediated liver regeneration in mice. Hepatology 55, 1215-1226.
25. Iwasaki T, Imado T, Kitano S, Sano H (2006). Hepatocyte growth factor ameliorates dermal sclerosis in the tight-skin mouse model of scleroderma. Arthritis Res Ther 8, R161.
26. Jing Q, Huang S, Guth S, Zarubin T, Motoyama A, Chen J, Di Padova F, Lin SC, Gram H, Han J (2005). Involvement of microRNA in AU-rich element-mediated mRNA instability. Cell 120, 623-634. (Pubitemid 40343075)
27. Kagoshima M, Kinoshita T, Matsumoto K, Nakamura T (1992). Developmental changes in hepatocyte growth factor mRNA and its receptor in rat liver, kidney and lung. Eur J Biochem 210, 375-380.
28. Kitamura K et al. (2007). Hepatocyte growth factor promotes endogenous repair and functional recovery after spinal cord injury. J Neurosci Res 85, 2332-2342. (Pubitemid 47204748)
29. Krek A et al. (2005). Combinatorial microRNA target predictions. Nat Genet 37, 495-500. (Pubitemid 40617277)
30. Lai WS, Carballo E, Strum JR, Kennington EA, Phillips RS, Blackshear PJ (1999). Evidence that tristetraprolin binds to AU-rich elements and promotes the deadenylation and destabilization of tumor necrosis factor alpha mRNA. Mol Cell Biol 19, 4311-4323. (Pubitemid 29242006)
31. Lijnen P, Petrov V (2002). Transforming growth factor-beta 1-induced collagen production in cultures of cardiac fibroblasts is the result of the appearance of myofibroblasts. Methods Find Exp Clin Pharmacol 24, 333-344. (Pubitemid 34857097)
32. Liu G, Friggeri A, Yang Y, Milosevic J, Ding Q, Thannickal VJ, Kaminski N, Abraham E (2010). miR-21 mediates fibrogenic activation of pulmonary fibroblasts and lung fibrosis. J Exp Med 207, 1589-1597.
33. Matsuda Y, Matsumoto K, Ichida T, Nakamura T (1995). Hepatocyte growth factor suppresses the onset of liver cirrhosis and abrogates lethal hepatic dysfunction in rats. J Biochem 118, 643-649.
34. Matsuda Y, Matsumoto K, Yamada A, Ichida T, Asakura H, Komoriya Y, Nishiyama E, Nakamura T (1997). Preventive and therapeutic effects in rats of hepatocyte growth factor infusion on liver fibrosis/cirrhosis. Hepatology 26, 81-89. (Pubitemid 27280310)
35. Matsumoto K, Nakamura T (1991). Hepatocyte growth factor: molecular structure and implications for a central role in liver regeneration. J Gastroenterol Hepatol 6, 509-519.
36. Matsumoto K, Nakamura T (1997). Hepatocyte growth factor (HGF) as a tissue organizer for organogenesis and regeneration. Biochem Biophys Res Commun 239, 639-644. (Pubitemid 27504153)
37. Matsumoto K, Tajima H, Okazaki H, Nakamura T (1992). Negative regulation of hepatocyte growth factor gene expression in human lung fibroblasts and leukemic cells by transforming growth factor-β1 and glucocorticoids. J Biol Chem 267, 24917-24920.
38. Mayoral RJ, Pipkin ME, Pachkov M, van Nimwegen E, Rao A, Monticelli S (2009). MicroRNA-221-222 regulate the cell cycle in mast cells. J Immunol 182, 433-445.
39. Miyazawa K, Kitamura A, Kitamura N (1991a). Structural organization and the transcription initiation site of the human hepatocyte growth factor gene. Biochemistry 30, 9170-9176.
40. Miyazawa K, Kitamura A, Naka D, Kitamura N (1991b). An alternatively processed mRNA generated from human hepatocyte growth factor gene. Eur J Biochem 197, 15-22.
41. Miyazawa K et al. (1989). Molecular cloning and sequence analysis of cDNA for human hepatocyte growth factor. Biochem Biophys Res Commun 163, 967-973. (Pubitemid 19236944)
42. Mizuno S, Matsumoto K, Kurosawa T, Mizuno-Horikawa Y, Nakamura T (2000). Reciprocal balance of hepatocyte growth factor and transforming growth factor-β1 in renal fibrosis in mice. Kidney Int 57, 937-948. (Pubitemid 30434784)
43. Mizuno S, Matsumoto K, Nakamura T (2001). Hepatocyte growth factor suppresses interstitial fibrosis in a mouse model of obstructive nephropathy. Kidney Int 59, 1304-1314. (Pubitemid 32281218)
44. Morishita R et al. (1999). Therapeutic angiogenesis induced by human recombinant hepatocyte growth factor in rabbit hind limb ischemia model as cytokine supplement therapy. Hypertension 33, 1379-1384. (Pubitemid 29282658)
45. Murakami Y, Toyoda H, Tanaka M, Kuroda M, Harada Y, Matsuda F, Tajima A, Kosaka N, Ochiya T, Shimotohno K (2011). The progression of liver fibrosis is related with overexpression of the miR-199 and 200 families. PloS One 6, e16081.
46. Nakamura T (1989). Molecular characterization of hepatocyte growth factor (HGF) [article in Japanese]. Seikagaku [J Japanese Biochem Soc] 61, 1243-1247.
47. Nakamura T, Mizuno S, Matsumoto K, Sawa Y, Matsuda H, Nakamura T (2000). Myocardial protection from ischemia/reperfusion injury by endogenous and exogenous HGF. J Clin Invest 106, 1511-1519. (Pubitemid 32038589)
48. Nakamura T, Nishizawa T, Hagiya M, Seki T, Shimonishi M, Sugimura A, Tashiro K, Shimizu S (1989). Molecular cloning and expression of human hepatocyte growth factor. Nature 342, 440-443. (Pubitemid 19277521)
49. Pandit KV et al. (2010). Inhibition and role of let-7d in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 182, 220-229.
50. Panganiban RA, Day RM (2011). Hepatocyte growth factor in lung repair and pulmonary fibrosis. Acta Pharmacol Sin 32, 12-20.
51. Patel V, Noureddine L (2012). MicroRNAs and fibrosis. Curr Opin Nephrol Hypertension 21, 410-416.
52. Rubin JS, Bottaro DP, Aaronson SA (1993). Hepatocyte growth factor/scatter factor and its receptor, the c-met proto-oncogene product. Biochim Biophys Acta 1155, 357-371. (Pubitemid 24012300)
53. Schaper W, Kubin T (1997). Is hepatocyte growth factor a protein with cardioprotective activity in the ischemic heart? Circulation 95, 2471-2472. (Pubitemid 27233109)
54. Shimamura M, Sato N, Waguri S, Uchiyama Y, Hayashi T, Iida H, Nakamura T, Ogihara T, Kaneda Y, Morishita R (2006). Gene transfer of hepatocyte growth factor gene improves learning and memory in the chronic stage of cerebral infarction. Hypertension 47, 742-751. (Pubitemid 43740247)
55. Stabile LP, Lyker JS, Land SR, Dacic S, Zamboni BA, Siegfried JM (2006). Transgenic mice overexpressing hepatocyte growth factor in the airways show increased susceptibility to lung cancer. Carcinogenesis 27, 1547-1555. (Pubitemid 44288043)
56. Thum T et al. (2008). MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts. Nature 456, 980-984.
57. Tolbert WD, Daugherty-Holtrop J, Gherardi E, Vande Woude G, Xu HE (2010). Structural basis for agonism and antagonism of hepatocyte growth factor. Proc Natl Acad Sci USA 107, 13264-13269.
58. Ueki T et al. (1999). Hepatocyte growth factor gene therapy of liver cirrhosis in rats. Nat Med 5, 226-230. (Pubitemid 29068532)
59. Umeda Y et al. (2004). Skeletal muscle targeting in vivo electroporation-mediated HGF gene therapy of bleomycin-induced pulmonary fibrosis in mice. Lab Invest 84, 836-844. (Pubitemid 38833243)
60. van Rooij E, Sutherland LB, Thatcher JE, DiMaio JM, Naseem RH, Marshall WS, Hill JA, Olson EN (2008). Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis. Proc Natl Acad Sci USA 105, 13027-13032.
61. Vettori S, Gay S, Distler O (2012). Role of microRNAs in fibrosis. Open Rheumatol J 6, 130-139.
62. Watanabe M et al. (2005). Hepatocyte growth factor gene transfer to alveolar septa for effective suppression of lung fibrosis. Mol Ther 12, 58-67. (Pubitemid 40862357)
63. Wilkie GS, Dickson KS, Gray NK (2003). Regulation of mRNA translation by 5′- and 3′-UTR-binding factors. Trends Biochem Sci 28, 182-188. (Pubitemid 36507156)
64. Willis BC, Borok Z (2007). TGF-β-induced EMT: mechanisms and implications for fibrotic lung disease. Am J Physiol Lung Cell Mol Physiol 293, L525-L534. (Pubitemid 47358808)
65. Yanagita K, Matsumoto K, Sekiguchi K, Ishibashi H, Niho Y, Nakamura T (1993). Hepatocyte growth factor may act as a pulmotrophic factor on lung regeneration after acute lung injury. J Biol Chem 268, 21212-21217.